eflornithine has been researched along with Carcinoma, Renal Cell in 4 studies
Eflornithine: An inhibitor of ORNITHINE DECARBOXYLASE, the rate limiting enzyme of the polyamine biosynthetic pathway.
eflornithine : A fluoroamino acid that is ornithine substituted by a difluoromethyl group at position 2.
Carcinoma, Renal Cell: A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pine, MJ | 1 |
| Huben, RP | 1 |
| Pegg, AE | 1 |
| Gohji, K | 2 |
| Murao, S | 1 |
| Maeda, S | 1 |
| Sugiyama, T | 1 |
| Kamidono, S | 2 |
| Fleischmann, J | 1 |
| Heston, WD | 1 |
| Bander, NH | 1 |
| Bauer, WC | 1 |
| Janney, C | 1 |
| Ratliff, TL | 1 |
| Fair, WR | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Urinary Excretion of Acetylamantadine by Cancer Patients[NCT02277938] | 120 participants (Anticipated) | Observational | 2013-08-31 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 other studies available for eflornithine and Carcinoma, Renal Cell
| Article | Year |
|---|---|
Production of N1-acetyl spermidine by renal cell tumors.
Topics: Animals; Carcinoma, Renal Cell; Carmustine; Eflornithine; Female; Kidney Neoplasms; Mice; Mice, Inbr | 1989 |
Enhanced inhibition of colony formation of human renal cell carcinoma in soft agar by the combination of alpha-difluoromethylornithine and recombinant gamma-interferon.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Cells, Cultured; Eflornithine | 1986 |
[Study on anticancer chemotherapy of human renal cell carcinoma. The combined effect of interferon and other anticancer drugs].
Topics: Antineoplastic Agents; Carcinoma, Renal Cell; Combined Modality Therapy; Eflornithine; Humans; Inter | 1987 |
Human renal cell carcinoma xenograft: morphology, growth and chemosensitivities.
Topics: Aged; Animals; Antibodies, Monoclonal; Antigens, Neoplasm; Antineoplastic Agents; Antineoplastic Com | 1985 |